| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1941.67 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 1346.88 | 97 |
| GSM780709 | Untreated after 4 days (C3_1) | 1116.26 | 96 |
| GSM780719 | Untreated after 4 days (C1_2) | 2321.69 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 1456.63 | 97 |
| GSM780721 | Untreated after 4 days (C3_2) | 1206.04 | 96 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1230.68 | 96 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1934.46 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1844.96 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1219.38 | 96 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1809.57 | 98 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1961.26 | 98 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1806.78 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1518.11 | 97 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1904.1 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 2221.06 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1480.82 | 97 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2019.95 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 2088.08 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1914.81 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1834.46 | 98 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1756.01 | 98 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 2000.65 | 98 |